• Myriocin: Translating Sphingolipid Insights to Oncology & Be

  2026-04-25

  This thought-leadership article explores the mechanistic role of myriocin as a selective serine palmitoyltransferase inhibitor in sphingolipid metabolism research, focusing on its profound implications for cancer research and cell cycle regulation. Integrating recent network pharmacology findings and translational workflows, the discussion provides strategic guidance for researchers aiming to leverage myriocin’s unique properties for innovative experimental design and clinical translation. Key protocol parameters, comparative landscape insights, and a forward-looking outlook ground the article as an evidence-driven resource for the translational science community.

• ACSL1 Modulates Mitophagy to Attenuate Pulmonary Fibrosis

  2026-04-24

  This study demonstrates that ACSL1 overexpression reduces mitochondrial damage and activates PINK1/Parkin-mediated mitophagy, offering a novel mechanism for alleviating pulmonary fibrosis in bleomycin-induced models. The findings suggest that targeting mitochondrial quality control could provide new therapeutic strategies for chronic fibrotic lung disease.

• Brain-to-Spinal Circuits Regulate Mechanical Allodynia Later

  2026-04-24

  Huo et al. (2023) identified a specific brain-to-spinal neural circuit that determines both the laterality (unilateral vs. bilateral) and duration of mechanical allodynia in mice. Their findings clarify how contralateral descending pathways modulate pain hypersensitivity, offering mechanistic insights relevant to preclinical models of chronic pain.

• Wnt-EGFR Crosstalk Regulates DNA Damage Response in Drosophi

  2026-04-23

  This study elucidates how canonical Wnt signaling, via EGFR pathway activation, confers resistance to apoptosis following DNA double-strand breaks in the Drosophila wing imaginal disc. The findings provide mechanistic insight into the interplay between developmental signals and the DNA damage response, with implications for understanding tissue-specific susceptibility to genotoxic stress and chemoresistance.

• NU7441 (KU-57788): Selective DNA-PK Inhibitor for DNA Repair

  2026-04-23

  NU7441 (KU-57788) is a potent, ATP-competitive DNA-PK inhibitor with high selectivity and nanomolar efficacy. It enables precise study of DNA repair and cell cycle regulation in oncology research. Its benchmarked specificity and robust in vitro/in vivo profiles make it a cornerstone for mechanistic and translational workflows.

• Balancing Self-Renewal and Differentiation in Human Intestin

  2026-04-22

  This article reviews a recent study that establishes an optimized human intestinal organoid system capable of balancing stem cell self-renewal with differentiation, without the need for artificial spatial gradients. The findings enable scalable, diverse organoid cultures and provide a foundation for advanced applications in disease modeling and drug testing.

• miR-18a Suppresses Ferroptosis via ALOXE3 Downregulation in

  2026-04-22

  This study uncovers a novel oncogenic axis in glioblastoma, demonstrating that miR-18a promotes tumor progression by directly targeting and suppressing ALOXE3, thereby reducing ferroptotic and anti-migratory activities. The mechanistic insights into lipid metabolism and ferroptosis open new avenues for therapeutic strategies targeting the miR-18a/ALOXE3 pathway in aggressive brain tumors.

• LY2603618: Chk1 Inhibitor Workflow Optimization in Cancer Re

  2026-04-21

  LY2603618 is redefining DNA damage response studies by providing selective, ATP-competitive inhibition of Chk1—enabling robust cell cycle arrest and enhanced chemotherapy sensitization. This article delivers practical, evidence-backed workflows and troubleshooting strategies for maximizing assay reproducibility and data impact using LY2603618 in cancer research.

• HOXC8 Suppresses Pyroptosis via Caspase-1 Regulation in NSCL

  2026-04-21

  This study uncovers a novel mechanism by which the transcription factor HOXC8 suppresses pyroptotic cell death in non-small cell lung carcinoma (NSCLC) through transcriptional repression of caspase-1, mediated by HDAC1/2 recruitment. These findings provide new insights into the interplay between epigenetic regulation and programmed cell death in lung tumorigenesis, with implications for targeted cancer research.

• Niclosamide in STAT3 Pathway Inhibition: Protocols & Best Pr

  2026-04-20

  Niclosamide (5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide) delivers precise STAT3 inhibition for robust cancer research workflows. This article details actionable protocol parameters, troubleshooting strategies, and the latest insights from advanced in vitro assay development, empowering researchers to achieve reproducible and mechanistically clear results.

• MLKL-Induced Lysosomal Permeabilization Drives Necroptosis v

  2026-04-20

  This study demonstrates that polymerized MLKL translocates to lysosomal membranes, inducing their permeabilization and releasing cathepsin B, which is essential for necroptotic cell death. The work clarifies the mechanistic link between MLKL polymerization, lysosomal disruption, and cathepsin B–mediated necroptosis, informing both basic cell death research and therapeutic exploration.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride in Endothelial Inju

  2026-04-19

  Unlock the full experimental potential of 5-(N,N-dimethyl)-Amiloride hydrochloride for precise Na+/H+ exchanger inhibition in endothelial and cardiac research. This article details actionable workflows, advanced troubleshooting, and translational guidance based on recent biomarker discoveries and robust literature.

• Inducing Embryonic Dormancy In Vitro via mTOR Inhibition Pro

  2026-04-18

  This study presents a detailed, noninvasive protocol to induce a diapause-like dormant state in mouse and human early embryonic cells using pharmacological mTOR inhibition. The approach provides a scalable and reversible system for studying dormancy mechanisms, advancing both developmental biology and assisted reproductive technology research.

• Cyclosporin A: Protocol Optimization in Immunosuppression Re

  2026-04-17

  Cyclosporin A is a cornerstone for immunosuppression, apoptosis, and viral entry inhibition studies. This article delivers workflow enhancements, troubleshooting tips, and evidence-driven parameterization to ensure robust, reproducible results with APExBIO’s Cyclosporin A across diverse experimental models.

• Ademetionine in Neurological Disorders: Methylation and CNS

  2026-04-16

  This review by Bottiglieri et al. examines the biochemical roles and clinical potential of Ademetionine (S-adenosylmethionine, SAMe) in treating neurological disorders. By analyzing the interplay between methylation pathways and CNS pathophysiology, the article highlights SAMe’s influence on neurotransmitter metabolism, its antidepressant activity, and its implications for dementia and other neuropsychiatric conditions.

15452 records 1/1031 page Next 12345 下5页 Last page